(Q38024661)

27 August 2017

title

Management of rheumatoid arthritis: the 2012 perspective (English)

1 reference

27 August 2017

1 reference

1

Hisashi Yamanaka

1 reference

27 August 2017

Yohei Seto

2

1 reference

27 August 2017

Eiichi Tanaka

3

1 reference

27 August 2017

Takefumi Furuya

4

1 reference

27 August 2017

Ayako Nakajima

5

1 reference

27 August 2017

Katsunori Ikari

6

1 reference

27 August 2017

Atsuo Taniguchi

7

1 reference

27 August 2017

Shigeki Momohara

8

1 reference

27 August 2017

publication date

7 July 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

23

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

1-7

1 reference

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Change of synovial vascularity in a single finger joint assessed by power doppler sonography correlated with radiographic change in rheumatoid arthritis: comparative study of a novel quantitative score with a semiquantitative score.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

New therapies in the management of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Comparative pharmacokinetics and tolerability of branded etanercept (25 mg) and its biosimilar (25 mg): a randomized, open-label, single-dose, two-sequence, crossover study in healthy Korean male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

The relationship between oral contraceptive use and functional outcome in women with recent-onset inflammatory polyarthritis: Results from the Norfolk Arthritis Register

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

A personal journey of discovery: developing technology and changing biology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Predictive, personalized, preventive, participatory (P4) cancer medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0702-1

Peripheral neuropathy in patients with systemic lupus erythematosus.

21 January 2018

1 reference

12 December 2020

Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study.

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Acute motor-sensory axonal neuropathy associated with active systemic lupus erythematosus and anticardiolipin antibodies

1 reference

12 December 2020

Acute lumbosacral polyradiculoneuropathy heralding transformation to systemic lupus erythematosus in a patient with discoid lupus

1 reference

12 December 2020

Systemic lupus erythematosus in the elderly

1 reference

12 December 2020

Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages.

1 reference

12 December 2020

Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment

1 reference

12 December 2020

Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature

1 reference

12 December 2020

Pathology of the motor-sensory axonal Guillain-Barré syndrome

1 reference

12 December 2020

Systemic lupus erythematosus in the elderly: clinical and immunological characteristics

1 reference

12 December 2020

10.3109/S10165-012-0702-1

Identifiers

DOI

1 reference

release_v5idnr75zrbghe6rk7bhhh7m5m

27 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v5idnr75zrbghe6rk7bhhh7m5m

24 November 2022

mapped directly with Wikidata item

1 reference